Gastrointestinal bleeding from Dieulafoy&rsquo;s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy

doi:10.4253/wjge.v7.i4.295

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12435)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-7) series.

Item

Count

PDF

776

WORD

350

HTML

9169

Figures (1-4)

157

Tables (1-7)

176

Sum=10628

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

832

Download

975

Sum=1807

Apr 16, 2015 (publication date) through Jun 4, 2024

Times Cited of This Article

Times Cited (69)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Endosc. Apr 16, 2015; 7(4): 295-307
Published online Apr 16, 2015. doi: 10.4253/wjge.v7.i4.295

Table 6 Effectiveness of endoscopic ablation monotherapies for bleeding Dieulafoy’s lesions

Endoscopic procedure(No. of patients)	Lesion location	Type of study	Follow-up	Outcome	Ref.
Heater probe coagulation
EGD (6)	Stomach/duodenum	Retrospective	14 mo (2/3 of pts)	No rebleeding	[35]
EGD (6)	Stomach	Retrospective	36 mo	2 (33%) rebled	[77]
Mostly EGD (5)	Mostly stomach/duodenum	Retrospective	Hospitalization	No rebleeding	[36]
EGD (1)	Stomach	Retrospective	40 mo	No rebleeding	[72]
Argon plasma coagulation
Double balloon enteroscopy (3)	Jejunum-2, Ileum-1	Retrospective /multicenter	14 mo	1 (33%) rebled	[17]
EGD (3)	Stomach	Retrospective	2 mo	No rebleeding	[40]
EGD (1)	Likely upper GI	Retrospective	Hospitalization	No rebleeding	[36]
Multipolar electrocoagulation
EGD (14)	Stomach	Retrospective	24 mo	1 (7%) hemostasis failure, 1 rebled	[82]
EGD (1)	Likely upper GI	Retrospective	Hospitalization	Rebled	[36]

Citation: Nojkov B, Cappell MS. Gastrointestinal bleeding from Dieulafoy’s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy. World J Gastrointest Endosc 2015; 7(4): 295-307
URL: https://www.wjgnet.com/1948-5190/full/v7/i4/295.htm
DOI: https://dx.doi.org/10.4253/wjge.v7.i4.295